Sunday, January 06, 2013 12:14:25 AM
Poon is good to listen to, btw - obvious why he's the Man in the Asian world when it comes to lead Dr.
I note you harp quite a bit on the 50% recurrence. I have no issues with that - it is WHEN that recurrence happens at question here.
I'll concur that there's one place where we'll see a lot of early PFS failures - when the second ablation attempt fails those patients will have PFS = 0 and will certainly drive the median lower than it "should" be.
Here's the ultimate problem with having a PFS lower than 12: Based on enrollment, you simply can't fit the necessary numbers into the 219 events known to have occurred around late Sept-2011 and the 380th around 11/9/12. If the 350 placebo patients had a median PFS of 10, we'd have hit 219 much earlier and the 380 MUCH earlier. Unless you want to argue that TDox is having an effect that lends somewhere around a 45-55 month PFS, on those same size tumors that RFA is NOT as effective on?
I'll listen to the other presentations you linked tomorrow, and whatever cc's I can stomach again.... but you haven't convinced me and I probably won't convince you. We're both bullish, so if you're right and it's 7v60, AWESOME.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM